Offer - Urjas Oil for just ₹ 1
Hoperab is an allopathic medicine The correct dosage of Hoperab depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Hoperab is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Hoperab safe for pregnant women?
Pregnant women can take Hoperab without worrying about any side effects.
Is the use of Hoperab safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Hoperab. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Hoperab on the Kidneys?
Using Hoperab does not have any harmful effects on kidneys.
What is the effect of Hoperab on the Liver?
Hoperab may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Hoperab on the Heart?
Hoperab is not harmful for the heart.
Hoperab should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Hoperab unless your doctor advises you to do so -
Is this Hoperab habit forming or addictive?
No, you will not get addicted to Hoperab.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Hoperab can make you feel drowsy.
Is it safe?
Yes, the use of Hoperab is considered safe.
Is it able to treat mental disorders?
No, Hoperab cannot treat any kind of mental disorder.
Interaction between Food and Hoperab
Taking Hoperab with food does not harm your health.
Interaction between Alcohol and Hoperab
Consuming Hoperab with alcohol can have many serious effects on your body.
Hoperab should be taken for as long as it is prescribed by your doctor. Do not stop taking it or take an extra dose on your own. Always follow the instructions of your doctor completely.
No, Hoperab is not an antibiotic. It belongs to the group of medications called proton pump inhibitor which blocks the excessive acid secretion in the stomach while antibiotics are the medicine that prevents and treats the infection caused by bacteria.
Rarely Hoperab causes stomach cancer. There has been no direct relationship to establish the fact. However, stomach cancer and other cancers may develop because of recurring acid reflux for a long time for example 7 - 8 years or more. If you feel any symptoms associated with cancer such as consistent low-grade fever, weight loss due to unexplained reasons, and pain in the abdomen, do not hesitate to get it diagnosed by a physician.
Yes, Hoperab is safe to take as long as it is prescribed by your doctor. However, in some people, it may produce some side effects like a headache, diarrhea, constipation, nausea, vomiting, sore throat and gas. If you suffer from any side effects, please inform your doctor immediately.
Yes, Hoperab use is associated with the development of diarrhea. This might be related to an infection caused by Clostridium difficile. If you experience severe diarrhea after consuming this medicine, inform the doctor right away without further delay. In addition, one must take a lot of electrolytes and fluids for preventing dehydration. Taking an anti-diarrheal medication may also help.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aciphex® (rabeprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1077-1078
